Zomedica Corp. Common Shares (ZOM)
ZOM moved a median of +0.08% 30 minutes after news, and -0.28% by the close. How ZOM actually reacts to news — the realized, point-in-time move the market made, measured across 161 labeled events over the last three years with zero look-ahead.
ZOM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.14% | 60% | 133 |
| 30-min | +0.08% | 53% | 133 |
| 60-min | 0.00% | 49% | 133 |
| to close | -0.28% | 43% | 133 |
| Middle 50% of ZOM reactions | -1.52% to +1.49% |
|---|---|
| Median reaction (30-min) | +0.08% |
| Measured reactions | 161 |
Half of all Zomedica Corp. Common Shares news events land between -1.52% and +1.49% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ZOM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ZOM's baseline. Nothing else.
Recent ZOM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Zomedica Announces "Fourth Friday at Four" Webinar on October 23, 2026: Zomedica's Clinical Program: How Evidence Drives Adoption | Press release | ACCESS Newswire | +6.13% | +9.88% | |
| Zomedica Announces Strategic Partnership with Veterinary Study Groups (VMG) to Deliver Advanced Veterinary Technologies to Independent Practices | Press release | ACCESS Newswire | +4.39% | -1.33% | |
| Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica’s Marketing Engine: How Demand Becomes Revenue | Press release | ACCESS Newswire | +6.44% | +2.49% | |
| Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform | Press release | ACCESS Newswire | -2.99% | -0.79% | |
| Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation | Press release | ACCESS Newswire | +2.54% | +8.24% | |
| Form 10-Q Zomedica Corp. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.37% | +3.79% | |
| Form 8-K Zomedica Corp. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -2.37% | +3.79% | |
| Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity | Press release | ACCESS Newswire | -2.37% | +3.79% | |
| Zomedica Launches the PulseVet Acoustic Muffler(TM) Accessory for PulseVet(R) Shock Wave System | Press release | ACCESS Newswire | +0.00% | -3.37% | |
| Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic | Press release | ACCESS Newswire | +0.59% | +0.30% | |
| Zomedica's Assisi Loop(R) Products Designated "Fear Free(R)" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC | Press release | ACCESS Newswire | -1.32% | +4.40% | |
| Form 8-K Zomedica Corp. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | +2.72% | +4.19% | |
| Zomedica Announces "Fourth Friday at Four" Webinar on June 26, 2026: The Five Pillars of Zomedica - Framework for Clinical Value and Shareholder Returns | Press release | ACCESS Newswire | -1.53% | +5.23% | |
| Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association | Press release | ACCESS Newswire | +1.17% | +4.49% | |
| Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market | Press release | ACCESS Newswire | -1.85% | -0.71% | |
| Form 10-Q Zomedica Corp. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -5.90% | +3.00% | |
| Form 8-K Zomedica Corp. For: May 06 | SEC filing · Form 8-K | SEC EDGAR | -5.90% | +3.00% | |
| Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity | Press release | ACCESS Newswire | -5.90% | +3.00% | |
| Form DEF 14A Zomedica Corp. For: Apr 24 | SEC filing · Form DEF | SEC EDGAR | -0.66% | -0.91% | |
| Form DEFA14A Zomedica Corp. | SEC filing · Form DEFA14A | SEC EDGAR | -0.66% | -0.91% | |
| Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale | Press release | ACCESS Newswire | +0.22% | +4.33% | |
| Form PRE 14A Zomedica Corp. For: Dec 31 | SEC filing · Form PRE | SEC EDGAR | -4.47% | -4.84% | |
| Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform | Press release | ACCESS Newswire | +8.00% | +4.80% | |
| Form 10-K Zomedica Corp. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +3.39% | +1.94% | |
| Form 8-K Zomedica Corp. For: Mar 16 | SEC filing · Form 8-K | SEC EDGAR | +3.39% | +1.94% | |
| Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity | Press release | ACCESS Newswire | +3.39% | +1.94% | |
| Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th "Fourth Friday at Four" Investor Webinar | Press release | ACCESS Newswire | -0.83% | +4.13% | |
| Zomedica Expands Distribution of TRUVIEW(R) Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary Pathology | Press release | ACCESS Newswire | -0.08% | +1.54% | |
| Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline | Press release | ACCESS Newswire | +0.70% | -5.05% | |
| Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity | Press release | ACCESS Newswire | +1.82% | +2.43% | |
| Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health | Press release | ACCESS Newswire | +0.36% | +10.40% | |
| Zomedica Announces "Fourth Friday at Four" Webinar on January 23rd Focused on Digital Innovation & Technology-Driven Growth | Press release | ACCESS Newswire | -2.53% | -2.40% | |
| Zomedica Launches Next-Generation VETGuardian PLUS(TM) Monitor, Expanding Core Monitoring Platform in Growing Veterinary Market | Press release | ACCESS Newswire | -0.40% | +2.01% | |
| Form 10-Q Zomedica Corp. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +8.32% | +5.33% | |
| Form 8-K Zomedica Corp. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +8.32% | +5.33% | |
| Form 8-A12G Zomedica Corp. | SEC filing · Form 8-A12G | SEC EDGAR | +0.00% | +4.86% | |
| Form 10-Q Zomedica Corp. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.27% | +7.73% | |
| Form 8-K Zomedica Corp. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +0.27% | +7.73% | |
| Zomedica to Present at the OTCQB Venture Virtual Investor Conference August 7th | Press release | GlobeNewswire | -7.07% | -6.22% | |
| Form 8-K Zomedica Corp. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | +1.98% | +9.30% | |
| Form DEFA14A Zomedica Corp. | SEC filing · Form DEFA14A | SEC EDGAR | -3.39% | +0.56% | |
| Form DEFA14A Zomedica Corp. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +7.62% | |
| Form 10-Q Zomedica Corp. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -5.09% | -14.91% | |
| Form 8-K Zomedica Corp. For: May 15 | SEC filing · Form 8-K | SEC EDGAR | -5.09% | -14.91% | |
| Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth | Press release | ACCESS Newswire | -5.09% | -14.91% | |
| Form DEFA14A Zomedica Corp. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +1.84% | |
| Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET | Press release | ACCESS Newswire | -2.04% | -0.74% | |
| Form 8-K Zomedica Corp. For: Apr 25 | SEC filing · Form 8-K | SEC EDGAR | -0.65% | +4.85% | |
| Form ARS Zomedica Corp. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -2.31% | -2.31% | |
| Form DEF 14A Zomedica Corp. For: Apr 30 | SEC filing · Form DEF | SEC EDGAR | -2.31% | -2.31% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ZOM section they belong to.
Where else ZOM is measured.
ZOM earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Matinas Biopharma Holdings, Inc. (MTNB) | 161 | -0.53% | 39% |
| NanoVibronix, Inc. (NAOV) | 161 | -0.40% | 39% |
| AVITA MEDICAL (AVMXY) | 160 | 0.00% | 46% |
| Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) | 159 | -1.17% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Zomedica Corp. Common Shares's median reaction calculated?
Every labeled ZOM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 161 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 53% of ZOM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ZOM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.